Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells

被引:300
作者
Fehniger, TA
Suzuki, K
Ponnappan, A
VanDeusen, JB
Cooper, MA
Florea, SM
Freud, AG
Robinson, ML
Durbin, J
Caligiuri, MA
机构
[1] Ohio State Univ, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Gunma Univ, Sch Med, Dept Urol, Gunma 3718511, Japan
[5] Childrens Hosp, Columbus, OH 43205 USA
[6] Res Inst, Columbus, OH 43205 USA
关键词
interleukin; 15; leukemia; transgenic mice; lymphocytes; inflammation;
D O I
10.1084/jem.193.2.219
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammation likely has a role in the early genesis of certain malignancies. Interleukin (IL)-15, a proinflammatory cytokine and growth factor, is required for lymphocyte homeostasis. Intriguingly, the expression of IL-15 protein is tightly controlled by multiple posttranscriptional mechanisms. Here, we engineered a transgenic mouse to overexpress IL-15 by eliminating these posttranscriptional checkpoints. IL-15 transgenic mice have early expansions in natural killer (NK) and CD8(+) T lymphocytes. Later, these mice develop fatal lymphocytic leukemia with a T-NK phenotype. These data provide novel evidence that leukemia, like certain other cancers, can arise as the result of chronic stimulation by a proinflammatory cytokine.
引用
收藏
页码:219 / 231
页数:13
相关论文
共 52 条
  • [11] At the crossroads of inflammation and tumorigenesis
    Cordon-Cardo, C
    Prives, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) : 1367 - 1370
  • [12] LYMPHOID DEVELOPMENT IN MICE WITH A TARGETED DELETION OF THE INTERLEUKIN-2 RECEPTOR-GAMMA CHAIN
    DISANTO, JP
    MULLER, W
    GUYGRAND, D
    FISCHER, A
    RAJEWSKY, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) : 377 - 381
  • [13] Interleukin-1 polymorphisms associated with increased risk of gastric cancer
    El-Omar, EM
    Carrington, M
    Chow, WH
    McColl, KEL
    Bream, JH
    Young, HA
    Herrera, J
    Lissowska, J
    Yuan, CC
    Rothman, N
    Lanyon, G
    Martin, M
    Fraumeni, JF
    Rabkin, CS
    [J]. NATURE, 2000, 404 (6776) : 398 - 402
  • [14] Cutting edge:: IL-15 costimulates the generalized Shwartzman reaction and innate immune IFN-γ production in vivo
    Fehniger, TA
    Yu, HX
    Cooper, MA
    Suzuki, K
    Shah, MH
    Caligiuri, MA
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (04) : 1643 - 1647
  • [15] Fehniger TA, 1999, J IMMUNOL, V162, P4511
  • [16] Interleukin 15: biology and relevance to human disease
    Fehniger, TA
    Caligiuri, MA
    [J]. BLOOD, 2001, 97 (01) : 14 - 32
  • [17] Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion
    Gärtner, F
    Alt, FW
    Monroe, R
    Chu, M
    Sleckman, BP
    Davidson, L
    Swat, W
    [J]. IMMUNITY, 1999, 10 (05) : 537 - 546
  • [18] Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells
    Gasser, S
    Corthésy, P
    Beerman, F
    MacDonald, HR
    Nabholz, M
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (11) : 5659 - 5667
  • [19] IDENTIFICATION AND CLONING OF A NOVEL IL-15 BINDING-PROTEIN THAT IS STRUCTURALLY RELATED TO THE ALPHA-CHAIN OF THE IL-2 RECEPTOR
    GIRI, JG
    KUMAKI, S
    AHDIEH, M
    FRIEND, DJ
    LOOMIS, A
    SHANEBECK, K
    DUBOSE, R
    COSMAN, D
    PARK, LS
    ANDERSON, DM
    [J]. EMBO JOURNAL, 1995, 14 (15) : 3654 - 3663
  • [20] UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15
    GIRI, JG
    AHDIEH, M
    EISENMAN, J
    SHANEBECK, K
    GRABSTEIN, K
    KUMAKI, S
    NAMEN, A
    PARK, LS
    COSMAN, D
    ANDERSON, D
    [J]. EMBO JOURNAL, 1994, 13 (12) : 2822 - 2830